Biased distal assemblies with locking mechanism

Information

  • Patent Grant
  • 12121439
  • Patent Number
    12,121,439
  • Date Filed
    Friday, September 24, 2021
    3 years ago
  • Date Issued
    Tuesday, October 22, 2024
    a month ago
  • Inventors
  • Original Assignees
  • Examiners
    • Tyson; Melanie R
    • Stuhlsatz; Cassidy N
    Agents
    • SLEMAN & LUND LLP
Abstract
System for fixation of native leaflets of a heart valve including an implantable fixation device including a center portion defining a longitudinal axis. The implantable fixation device further includes a first distal assembly having a first distal strut pivotally-coupled with the center portion and a first distal element pivotally-coupled with the first distal strut. The first distal assembly is configured to move between a closed position and an extended position. The implantable fixation device further includes a second distal assembly having a second distal strut pivotally-coupled with the center portion and a second distal element pivotally-coupled with the second distal strut. The second distal assembly is configured to move between a closed position and an extended position. The implantable fixation device further includes a locking mechanism configured to lock the first distal assembly and second distal assembly in a selected locked position between the closed position and the extended position.
Description
FIELD OF DISCLOSED SUBJECT MATTER

The disclosed subject matter is directed to medical devices for the endovascular, percutaneous or minimally invasive surgical treatment of bodily tissues, such as tissue approximation or valve repair. More particularly, the present disclosure relates to repair of valves of the heart and venous valves.


Surgical repair of bodily tissues can involve tissue approximation and fastening of such tissues in the approximated arrangement. When repairing valves, tissue approximation includes coapting the leaflets of the valves in a therapeutic arrangement which can then be maintained by fastening or fixing the leaflets. Such coaptation can be used to treat regurgitation, which commonly occurs in the mitral valve and in the tricuspid valve.


Mitral valve regurgitation is characterized by retrograde flow from the left ventricle of a heart through an incompetent mitral valve into the left atrium. During a normal cycle of heart contraction (systole), the mitral valve acts as a check valve to prevent flow of oxygenated blood back into the left atrium. In this way, the oxygenated blood is pumped into the aorta through the aortic valve. Regurgitation of the mitral valve can significantly decrease the pumping efficiency of the heart, placing the patient at risk of severe, progressive heart failure.


Mitral valve regurgitation can result from a number of different mechanical defects in the mitral valve or the left ventricular wall. The valve leaflets, the valve chordae which connect the leaflets to the papillary muscles, the papillary muscles or the left ventricular wall can be damaged or otherwise dysfunctional. Commonly, the valve annulus can be damaged, dilated, or weakened limiting the ability of the mitral valve to close adequately against the high pressures of the left ventricle.


DESCRIPTION OF RELATED ART

Treatments for mitral valve regurgitation rely on valve replacement or repair including leaflet and annulus remodeling, the latter generally referred to as valve annuloplasty. Another technique for mitral valve repair, which relies on suturing adjacent segments of the opposed valve leaflets together is referred to as the “bow-tie” or “edge-to-edge” technique. Preferably, the use of devices and systems should not require open chest access and, rather, be capable of being performed either endovascularly, i.e., using devices, such as a catheter, which are advanced to the heart from a point in the patient's vasculature remote from the heart. Furthermore, such devices and systems should allow for repositioning and optional removal of a fixation device (i.e., valve repair clip) prior to fixation to ensure optimal placement. Such devices and systems likewise can be useful for repair of tissues in the body other than heart valves.


SUMMARY

The purpose and advantages of the disclosed subject matter will be set forth in and apparent from the description that follows, as well as will be learned by practice of the disclosed subject matter. Additional advantages of the disclosed subject matter will be realized and attained by the methods and systems particularly pointed out in the written description and claims hereof, as well as from the appended drawings.


To achieve these and other advantages and in accordance with the purpose of the disclosed subject matter, as embodied and broadly described, the disclosed subject matter is directed to a fixation device for treating a patient.


In accordance with the disclosed subject matter, a system for fixation of native leaflets of a heart valve including an implantable fixation device including a center portion defining a longitudinal axis. The implantable fixation device further includes a first distal assembly having a first distal strut pivotally-coupled with the center portion and a first distal element pivotally-coupled with the first distal strut. The first distal assembly is configured to move between a closed position with the first distal strut folded proximate the center portion and the first distal element folded proximate the first distal strut, and an extended position with the first distal strut extending distally from the center portion and the first distal element extends distally from the first distal strut. The first distal assembly is biased towards the closed position. The implantable fixation device further includes a second distal assembly having a second distal strut pivotally-coupled with the center portion and a second distal element pivotally-coupled with the second distal strut. The second distal assembly is configured to move between a closed position with the second distal strut folded proximate the center portion and the second distal element folded proximate the second distal strut, and an extended position with the second distal strut extending distally from the center portion and the second distal element extending distally from the second distal strut. The second distal assembly is biased towards the closed position.


The implantable fixation device further includes a first proximal element having a first gripping portion. The first gripping portion is moveable relative to the first distal assembly to capture native leaflet tissue therebetween. The implantable fixation device further includes a second proximal element having a second gripping portion. The second gripping portion is moveable relative to the second distal assembly to capture native leaflet tissue therebetween. The implantable fixation device further includes a locking mechanism configured to lock the first distal assembly and second distal assembly in a selected locked position between the closed position and the extended position.


In accordance with the disclosed subject matter, the center portion can include a smooth surface. The center portion can be configured to obstruct regurgitant blood flow between native leaflets of the heart valve. Each of the first and second distal assemblies can comprise a plurality of stamped metal components having at least one rivet attachment. Each of the first and second distal assemblies can be made of a single-piece, braided structure. The first and second distal assemblies can be biased towards the closed position by at least one spring. The at least one spring can produce between about 0.10 lbf and 0.50 lbf of closure force at each of the first and second distal struts measured proximate a location of coupling between the first and second distal struts and the first and second distal elements, respectively. The implantable fixation device can further include an actuator shaft operatively connected to the first and second distal assemblies, and the at least one spring is an axial spring operatively connected to the actuator shaft. Additionally or alternatively, the at least one spring can be a torsion spring operatively connected to at least one pivot point of each of the first and second distal assemblies. Additionally or alternatively, each of the first and second distal assemblies can include a flexural member configured to bias each of the first and second distal assemblies towards the closed position, wherein the flexural member can be made of nitinol and can include a beam structure selected from the group consisting of a slotted beam, a solid beam, and a hinged beam. Further, each of the flexural members can comprise a living hinge at a pivot point of the first and second distal assemblies, respectively, with the strain-free condition set in the fully closed condition.


Further, each of the first and second proximal elements can be attached to the center portion. Alternatively, the first proximal element can be attached to the first distal strut and the second proximal element can be attached to the second distal strut.


In accordance with another aspect of the disclosed subject matter, the locking mechanism can include a binding plate configured to lock each of the first and second distal assemblies when the binding plate is at an angled orientation relative to the longitudinal axis and further configured to unlock each of the first and second distal assemblies when the binding plate is at a perpendicular orientation relative to the longitudinal axis.


Additionally, the system for fixation can further include a delivery device releasably attached to the implantable fixation device, the delivery device can include an actuator rod, wherein the implantable fixation device can be releasably attached to the implantable fixation device at a distal end of the actuator rod. The actuator rod can be rotatable and can include a threaded fastener at the distal end thereof. The threaded fastener can be configured to connect to the implantable fixation device by a threaded connection. Distal movement of the actuator rod moves each of the first and second distal assemblies towards the extended position, and proximal movement of the actuator rod moves each of the first and second distal assemblies towards the closed position.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 is a front view of an exemplary embodiment of an implantable fixation device for use in accordance with the disclosed subject matter, the implantable fixation device having distal assemblies in the extended position.



FIGS. 2A-2C are front views of the implantable fixation device of FIG. 1, wherein the distal assemblies are in various non-extended positions.



FIGS. 3A-3D are front views of an alternative implantable fixation device including an axial spring.



FIGS. 4A-C are front views of an alternative implantable fixation device including a torsion spring.



FIGS. 5A-5D are front views of an alternative implantable fixation device having proximal elements attached to distal struts.



FIG. 6 is a front view of the implantable fixation device of FIGS. 3A-3D and a delivery device configured for releasable attachment.



FIG. 7 is a front view of the implantable fixation device of FIGS. 5A-5D further depicting suture lines attached to the proximal elements.





DETAILED DESCRIPTION

Reference will now be made in detail to the various exemplary embodiments of the disclosed subject matter, exemplary embodiments of which are illustrated in the accompanying drawings.


The fixation device for use with the disclosed subject matter provides an edge-to-edge transcatheter valve repair option for patients having various conditions, including regurgitant mitral valves or tricuspid valves. Transcatheter (e.g., trans-septal) edge-to-edge valve repair has been established using a fixation device. These fixation devices generally are configured to capture and secure opposing native leaflets using two types of leaflet contacting elements. The first element is a sub-valvular element to contact the ventricular side of a native leaflet to be grasped. With the sub-valvular element positioned underneath to stabilize the native leaflet in a beating heart, a second elastic proximal element can be lowered or moved toward the sub-valvular element and into contact with the atrial side of the native leaflet to capture the leaflet therebetween. Once each native leaflet is captured by a respective sub-valvular and proximal element, the fixation device can be closed by raising or moving the sub-valvular element toward a center of the fixation device such that the leaflets are brought into coaptation, which results in a reduction in valvular regurgitation during ventricular systole. Furthermore, a covering can be provided on the sub-valvular and/or proximal element to facilitate tissue ingrowth with the captured leaflets.


Additional details of exemplary fixation devices in accordance with the disclosed subject matter are set forth below. Furthermore, a number of patents and publications disclose additional details and aspects of related fixation devices and operations. See for example, U.S. Pat. No. 7,226,467 to Lucatero et al.; U.S. Pat. No. 7,563,267 to Goldfarb et al.; U.S. Pat. No. 7,655,015 to Goldfarb et al.; U.S. Pat. No. 7,736,388 to Goldfarb et al.; U.S. Pat. No. 7,811,296 to Goldfarb et al.; U.S. Pat. No. 8,057,493 to Goldfarb et al.; U.S. Pat. No. 8,303,608 to Goldfarb et al.; U.S. Pat. No. 8,500,761 to Goldfarb et al.; U.S. Pat. No. 8,734,505 to Goldfarb et al.; U.S. Pat. No. 8,740,920 to Goldfarb et al.; U.S. Pat. No. 9,510,829 to Goldfarb et al.; U.S. Pat. No. 7,635,329 to Goldfarb et al.; U.S. Patent Application Publication No. 2017/0042546 to Goldfarb et al.; U.S. Patent Application Publication No. 2017/0239048 to Goldfarb et al.; U.S. Patent Application Publication No. 2018/0325671 to Abunassar et al., the entirety of the contents of each of these patents and published applications is incorporated herein by reference.


In fixing leaflets of a heart valve, an implantable fixation device with sub-valvular elements can be self-closing (i.e., biased towards a closed position), which can have advantages for simplifying an implantation procedure. Self-closing sub-valvular elements can be in a final closing angle when a total leaflet resistance force and an internal self-closing force of the sub-valvular elements are equal, thus creating a final equilibrium closing angle. In various circumstances, there are advantages to manually adjusting and fine tuning the final closing angle, thereby modifying the angle to be more open or closed as compared to final equilibrium closing angle. This can allow a user to improve performance of the implantable fixation device in certain situations (e.g., in patients having certain abnormal valve anatomies). When the closing angle is modified, this allows for a direct impact on the tradeoff between regurgitation reduction and diastolic pressure gradient, which is associated with valve stenosis.


In some situations, it can be beneficial to selectively open the angle from the equilibrium closing angle. For example, for relatively small valves, opening the angle can reduce leaflet coaptation to allow more forward blood flow, and thus reduce the possibility of a high gradient. Likewise, when leaflets are particularly vulnerable (e.g., thin, friable, short, or calcified) opening the angle can reduce forces on the leaflets and consequently reduce the probability of a leaflet tear. Alternatively, in other situations and circumstances, it can conversely be beneficial to selectively close the angle beyond the equilibrium closing angle. For example, for valves having abnormally large gaps between leaflets, further closing the angle can reduce excessive regurgitation and improve grasping performance, thus reducing the probability of requiring additional implanted devices to sufficiently reduce regurgitation. Likewise, for valves having uneven leaflets, further closing the angle can ensure the thinner of the two leaflets is sufficiently grasped. Indeed, in a purely self-closing device grasping uneven leaflets, the device will only close to the point of first resistance, such as when the thicker of two inserted leaflets is contacted, which can leave the thinner leaflet insufficiently grasped.


Accordingly, a self-closing (biased closed) device can be combined with one or more additional features, such as a locking mechanism, to enable manual selection and fine-tuning of the final closed angle.


Generally, and as set forth in greater detail below, the disclosed subject matter provided herein includes a system for fixation of native leaflets of a heart valve including an implantable fixation device including a center portion defining a longitudinal axis. The implantable fixation device further includes a first distal assembly having a first distal strut pivotally-coupled with the center portion and a first distal element pivotally-coupled with the first distal strut. The first distal assembly is configured to move between a closed position with the first distal strut folded proximate the center portion and the first distal element folded proximate the first distal strut, and an extended position with the first distal strut extending distally from the center portion and the first distal element extends distally from the first distal strut. The first distal assembly is biased towards the closed position. The implantable fixation device further includes a second distal assembly having a second distal strut pivotally-coupled with the center portion and a second distal element pivotally-coupled with the second distal strut. The second distal assembly is configured to move between a closed position with the second distal strut folded proximate the center portion and the second distal element folded proximate the second distal strut, and an extended position with the second distal strut extending distally from the center portion and the second distal element extending distally from the second distal strut. The second distal assembly is biased towards the closed position.


The implantable fixation device further includes a first proximal element having a first gripping portion. The first gripping portion is moveable relative to the first distal assembly to capture native leaflet tissue therebetween. Likewise, the implantable fixation device further includes a second proximal element having a second gripping portion. Similarly, the second gripping portion is moveable relative to the second distal assembly to capture native leaflet tissue therebetween. Additionally, the implantable fixation device further includes a locking mechanism configured to lock the first distal assembly and second distal assembly in a selected locked position between the closed position and the extended position.


Referring to FIGS. 1 and 2A-2C, for the purpose of illustration and not limitation, a system for fixation of native leaflets of a heart valve includes an implantable fixation device 102 comprising a center portion 104 defining a longitudinal axis 106. Additionally, the center portion 104 can include a smooth surface. The smooth surface finish can the provide favorable blood flow obstruction characteristics. The center portion 104 can be configured to obstruct regurgitant blood flow between native leaflets of the heart valve. Furthermore, the center portion 104 can be configured as a spacer in the valve providing a leaflet sealing surface.


In accordance with the disclosed subject matter, the implantable fixation device 102 further includes a first distal assembly 108 comprising a first distal strut 110 pivotally-coupled with the center portion 104 and a first distal element 112 pivotally-coupled with the first distal strut 110. The first distal assembly 108 is configured to move between a closed position with the first distal strut 110 folded proximate the center portion 104 and the first distal element 112 folded proximate the first distal strut 110, and an extended position with the first distal strut 110 extending distally from the center portion 104 and the first distal element 112 extending distally from the first distal strut 110. The first distal assembly 108 is biased towards the closed position. The implantable fixation device 102 further includes a second distal assembly 114 comprising a second distal strut 116 pivotally-coupled with the center portion 104 and a second distal element 118 pivotally-coupled with the second distal strut 116. The second distal assembly 114 is configured to move between a closed position with the second distal strut 116 folded proximate the center portion 104 and the second distal element 118 folded proximate the second distal strut 116, and an extended position with the second distal strut 116 extending distally from the center portion 104 and the second distal element 118 extending distally from the second distal strut 116. Furthermore, the second distal assembly 114 is biased towards the closed position.


As embodied herein, each of the first and second distal assemblies 108, 114 can comprise a plurality of stamped metal components having at least one rivet attachment 160 attached to a base 143. For example, the distal elements 112, 118 and distal struts 110, 116 may be stamped metal components with various rivet attachment 160 connections connected to base 143, as shown for purpose of illustration and not limitation in FIG. 1. Additionally or alternatively, each of the first and second distal assemblies 108, 114 can be made of a single-piece, braided structure. As another example, each of the first and second distal assemblies can be made of laser-cut metallic sheet structures or nitinol shape-set structures.


The extended position can be a fully inverted position of the distal elements 112, 118 configured for delivery of the implantable fixation device 102 and further configured for complete leaflet release. The first and second distal assemblies 108, 114 can be configured to capture a leaflet at various positions between the closed position and the extended position, such as when the angle between the first distal element 112 and the second distal element 118 is between about 110 and 130 degrees, and preferably about 120 degrees. FIG. 2A depicts the first and second distal assemblies 108, 114 in the closed position, and FIGS. 2B and 2C depict the first and second distal assemblies 108, 114 in various positions between the closed and extended positions. The first and second distal assemblies 108, 114 can be sub-valvular elements configured to contact the ventricular side of a native leaflet to be grasped.


In accordance with the disclosed subject matter, and with continued reference to FIG. 1, the implantable fixation device includes a first proximal element 120 having a first gripping portion 122, wherein the first gripping portion 122 is moveable relative to the first distal assembly 108 to capture native leaflet tissue therebetween. Likewise, the implantable fixation device further includes a second proximal element 124 having a second gripping portion 126, wherein the second gripping portion 126 is moveable relative to the second distal assembly 114 to capture native leaflet tissue therebetween. Each of the first and second proximal elements 120, 124 can be attached to the center portion 104. As embodied herein, each proximal element 120, 124 can includes a plurality of friction elements, for example in rows. The friction elements can allow for improved tissue engagement during leaflet capture. In leaflet capture, each first and second proximal element 120, 124 can be lowered or moved toward each respective first and second distal assembly 108,114 and into contact with the atrial side of the native leaflet to capture the leaflet therebetween. The proximal elements 120, 124 and friction elements are described further in the disclosures of the patents and applications incorporated in their entirety by reference herein.


The implantable fixation device, as depicted, further includes a locking mechanism 128 configured to lock the first distal assembly 108 and second distal assembly 114 in a selected locked position between the closed position and the extended position. As shown, and for purpose of illustration and not limitation, the locking mechanism 128 can include a binding plate 144 configured to lock each of the first and second distal assemblies 108, 114 when the binding plate 144 is at an angled orientation relative to the longitudinal axis 106. Further the locking mechanism 128 is configured to unlock each of the first and second distal assemblies 108, 114 when the binding plate 144 is at a perpendicular orientation relative to the longitudinal axis 106. For example, when the binding plate 144 is at the perpendicular orientation, the binding plate 144 can have an internal hole that is clear of an actuator shaft 132 and when the binding plate 144 is in the angled orientation the actuator shaft is engaged and the distal assemblies 108, 114 are locked. Additionally, the locking mechanism 128 can include a release mechanism to remotely control the binding plate 144. The state of the distal assemblies 108, 114 can be actuated between the positions shown in FIGS. 1-2C. Distal movement of the actuator shaft 132 can be arrested by the locking mechanism 128, which therefore provides a one-way lock that prevents the device from opening from more a closed position to a more open position. The actuator shaft 132 may be coupled to base 143, as shown in FIG. 1, such that proximal-distal movement of the actuator shaft 132 correspondingly moves base 142 and moves the first distal assembly 108 and the second distal assembly 114, which may be attached to base 143, between the closed and extended positions. During a procedure, the lock can be remotely configured to an unlocked position by applying tensile force to the binding plate 144. A user may leave the device in an unlocked position for an entire length of a procedure, if desired. Alternatively, the user can only be unlock the device actuating the device to a more open position. As embodied herein, the locking mechanism 128 can comprise a release harness 140, which can adjust the orientation of the binding plate 144 to a perpendicular orientation after a proximal force is applied remotely by from a user (e.g., via a suture connected to the harness). The binding plate 144 can have a locked default angled orientation from a leaf spring component that biases the binding plate. Unlocking the binding plate can unlock the binding plate 144 to a perpendicular orientation relative the longitudinal axis 106 as the leaf spring is compressed elastically. This unlocking force input from is applied by the user through a suture, cable, or line extending through the catheter from a handle to the locking mechanism 128. For simplicity, the lock can be only active on a distal portion of the actuator shaft 132, which can be constructed with a larger diameter than a proximal portion of the actuator shaft 132. Distal portion of the actuator shaft can be made with a rough surface finish such that the lock only functions on the rough surface. A version of the desired locking mechanism 128 is described in U.S. Pat. No. 7,604,646, however, the position of the locking mechanism is modified herein. Further, the locking mechanism 128 in accordance with the disclosed subject matter can include additional and alternative aspects, such as those described in U.S. Pat. No. 7,604,646, the entirety of the contents of which are incorporated herein by reference.


Referring to FIGS. 3A-3D, for illustration and not limitation, the first and second distal assemblies 108, 114 can be biased towards the closed position by at least one spring 130. The at least one spring 130 can produce between about 0.10 lbf and 0.50 lbf of closure force at each of the first and second distal struts 110, 116 at an outer-most location of leaflet contact, which is located proximate a location of coupling between the first and second distal struts 110, 116 and the first and second distal elements 112, 118, respectively. Furthermore, the closure force can resist an anticipated maximum load of about 0.1 to 0.3 lbf with a factor of safety of 2 to 5, or a force range of 0.2 lbf to 1 lbf at a location proximate the location of coupling. FIG. 3D depicts the first and second distal assemblies 108, 114 in the closed position wherein the at least one spring 130 is at a lowest-strain energy state. FIGS. 3B and 3C depict the first and second distal assemblies 108, 114 in various positions between the closed and extended positions, likewise with the at least one spring in various corresponding strain energy states. Additionally, the implantable fixation device can further include an actuator shaft 132 operatively connected to the first and second distal assemblies 108, 114. Further, and as disclosed herein, the at least one spring 130 can be an axial spring 134 operatively connected to the actuator shaft 132. Alternatively, the at least one spring 130 can be a non-axial linear spring. The at least one spring 130 can alternatively be a constant-force spring or a non-linear spring.


In accordance with the disclosed subject matter, FIGS. 4A-4C illustrate for the purpose of illustration and limitation, that the at least one spring 130 can be a torsion spring 136 operatively connected to at least one pivot point 142 of each of the first and second distal assemblies 108, 114. FIG. 4A depicts the first and second distal assemblies 108, 114 in the closed position wherein the torsion spring 136 is at a lowest-strain energy state. FIGS. 4B and 4C depict the first and second distal assemblies 108, 114 in various positions between the closed and extended positions, likewise with the torsion spring 136 in various corresponding strain energy states.


Additionally or alternatively, each of the first and second distal assemblies 108, 114 can include a flexural member 138 configured to bias each of the first and second distal assemblies 108, 114 towards the closed position. The flexural member 138 can be made of nitinol and can comprise a beam structure 139 selected from the group consisting of a slotted beam, a solid beam, and a hinged beam. Furthermore, each of the flexural members 138 can include a living hinge at a pivot point 142 of the first and second distal assemblies 108, 114, respectively. The flexural members 138 can be integral with any element of the distal assemblies 108, 114. The flexural members can be set to a preferred lowest-strain energy configuration when the distal assemblies 108, 114 are in the closed position by means of shape setting nitinol.


For any biasing mechanism of the disclosed subject matter (e.g., the spring or flexural members), strain energy can be at a lowest-strain energy state when the distal assemblies are fully closed. Further, the biasing mechanism can have an additional lowest-strain energy state when the distal assemblies are fully extended such the that the distal assemblies can also be biased to the extended position. For example, the distal assemblies can be biased to the extended position during delivery, and as the distal assemblies move towards the closed position, the bias can switch to the closed position.


In accordance with another embodiment of the disclosed subject matter, and as shown in FIGS. 5A-D for the purpose of illustration and not limitation, the first proximal element 120 can be attached to the first distal strut 110 and the second proximal element 124 can be attached to the second distal strut 116. Attachment of the proximal element to the distal strut can enable the movement of the distal strut and the proximal element together, which can improve the ability to capture leaflets at relatively open positions of the distal assembly 108, such as the position shown in FIG. 2C. As shown, FIG. 5A depicts the first and second distal assemblies 108, 114 in the closed position, FIG. 5D depicts the first and second assemblies 108, 114 in the extended position and FIGS. 5B-5C depicts the first and second assemblies 108, 114 in various positions between the closed and extended positions.


In accordance with an additional aspect of the subject matter disclosed herein, FIG. 6 depicts, for the purpose of illustration and not limitation, that the system for fixation can include a delivery device 146 releasably attached to the implantable fixation device 102. As shown, the delivery device 146 can include an actuator rod 148, wherein the implantable fixation device 102 can be releasably attached to the implantable fixation device 102 at a distal end 150 of the actuator rod. Furthermore, the actuator rod 148 can be rotatable and comprise a threaded fastener 152 at the distal end 150 thereof. The threaded fastener 152 can be configured to connect to the implantable fixation device 102 by a threaded connection. Furthermore, distal movement of the actuator rod 148 can move each of the first and second distal assemblies 108, 114 towards the extended position, and proximal movement of the actuator rod 148 can move each of the first and second distal assemblies 108, 114 towards the closed position.


In accordance with a further aspect of the disclosed subject matter, and as further embodied herein in FIG. 7, each of the first and second proximal elements 120, 124 can be biased toward each respective first and second distal assembly 108, 114. Prior to leaflet capture, each proximal element 120, 124 can be moved inwardly toward the longitudinal axis, and, as depicted, held with the aid of one or more proximal element lines 156. The proximal element lines 156 can be in the form of sutures, wires, rods, cables, polymeric lines, or other suitable structures. Furthermore, the one or more proximal element lines 156 can be operatively connected with the first and second proximal elements 120, 124 in a variety of ways, such as by being threaded through loops (not shown) disposed on the first and second proximal elements 120, 124. For purpose of illustration and not limitation, a first proximal element line can be connected to the first proximal element 120 and a second proximal element line can be connected to the second proximal element 124. In leaflet capture, the proximal element lines 156 can lower each first and second proximal element 120, 124 toward each respective first and second distal assembly 108, 114 and into contact with the atrial side of the native leaflet to capture the leaflet therebetween. The proximal element lines 156 are described further in the disclosures of the patents and applications incorporated in their entirety by reference herein.


The embodiments illustrated herein are adapted for repair of a heart valve, such as a mitral valve or a tricuspid valve, using an antegrade approach from a patient's left or right atrium. Prior to a procedure, imaging and various tests can be performed to anticipate and diagnose a patient's individual circumstances and assist a physician in selecting the locked position. For example, when a patient is exhibiting severe backflow, the physician can selectively lock the distal assemblies 108, 114 in the closed position or at an angle of about 10-20 degrees between the first distal element 112 and the second distal element 118. Conversely, when a physician observes significant obstruction to forward flow through the valve being treated, which is termed valve stenosis and characterized by a high pressure gradient across the valve, the physician can elect lock the device at a wider angle of about 30-45 degrees.


While the disclosed subject matter is described herein in terms of certain preferred embodiments for purpose of illustration and not limitation, those skilled in the art will recognize that various modifications and improvements can be made to the disclosed subject matter without departing from the scope thereof. Moreover, although individual features of one embodiment of the disclosed subject matter can be discussed herein or shown in the drawings of one embodiment and not in other embodiments, it should be readily apparent that individual features of one embodiment can be combined with one or more features of another embodiment or features from a plurality of embodiments.


In addition to the specific embodiments claimed below, the disclosed subject matter is also directed to other embodiments having any other possible combination of the dependent features claimed below and those disclosed above. As such, the particular features presented in the dependent claims and disclosed above can be combined with each other in other possible combinations. Thus, the foregoing description of specific embodiments of the disclosed subject matter has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the disclosed subject matter to those embodiments disclosed.


It will be apparent to those skilled in the art that various modifications and variations can be made in the system of the disclosed subject matter without departing from the spirit or scope of the disclosed subject matter. Thus, it is intended that the disclosed subject matter include modifications and variations that are within the scope of the appended claims and their equivalents.

Claims
  • 1. A system for fixation of native leaflets of a heart valve comprising: an implantable fixation device comprising: a center portion defining a longitudinal axis;a first distal assembly comprising a first distal strut having a first end pivotally-coupled with the center portion and an opposite second end pivotally-coupled with a first distal element, the first distal assembly configured to move between a closed position with the first distal strut folded adjacent the center portion and the first distal element folded adjacent a surface of the first distal strut opposite the center portion, and an extended position with the first distal strut extending distally from the center portion and the first distal element extending distally from the first distal strut, wherein the first distal assembly is spring biased towards the closed position;a second distal assembly comprising a second distal strut having a first end pivotally-coupled with the center portion and an opposite second end pivotally-coupled with a second distal element, the second distal assembly configured to move between a closed position with the second distal strut folded adjacent the center portion and the second distal element folded adjacent a surface of the second distal strut opposite the center portion, and an extended position with the second distal strut extending distally form the center portion and the second distal element extending distally from the second distal strut, wherein the second distal assembly is spring biased towards the closed position;an actuator shaft coupled to the first and second distal assemblies and being configured to move the first and second distal assemblies between their respective closed and extended positions upon proximal-distal movement of the actuator shaft;a first proximal element having a first gripping portion, the first gripping portion being moveable relative to the first distal assembly to capture native leaflet tissue therebetween;a second proximal element having a second gripping portion, the second gripping portion being moveable relative to the second distal assembly to capture native leaflet tissue therebetween; anda locking mechanism configured to lock the first distal assembly and second distal assembly in a selected locked position between the closed position and the extended position; anda delivery device releasably attached to the implantable fixation device, the delivery device comprising an actuator rod extending therefrom and being releasably engaged to the actuator shaft, the actuator rod being configured to move the actuator shaft in the proximal-distal direction,wherein the locking mechanism is disposed along the longitudinal axis proximal to the center portion and comprises a binding plate and a release harness, the actuator shaft extending through the binding plate and the release harness, the binding plate being disposed within the release harness, and the release harness being configured to adjust an orientation of the binding plate between an angled orientation relative to the actuator shaft to lock each of the first and second distal assemblies and a perpendicular orientation relative to the actuator rod shaft to unlock each of the first and second distal assemblies.
  • 2. The system of claim 1, wherein the center portion comprises a smooth surface.
  • 3. The system of claim 1, wherein the center portion is configured to obstruct regurgitant blood flow between native leaflets of the heart valve.
  • 4. The system of claim 1, wherein each of the first and second distal assemblies comprises a plurality of stamped metal components pivotally-coupled by at least one rivet attachment.
  • 5. The system of claim 1, wherein each of the first and second distal assemblies is made of a single-piece, braided structure.
  • 6. The system of claim 1, wherein the first and second distal assemblies are spring biased towards the closed position by at least one spring.
  • 7. The system of claim 6, wherein the at least one spring produces between about 0.10 lbf and 0.50 lbf of closure force at each of the first and second distal struts, measured proximate a location of coupling between the first and second distal struts and the first and second distal elements.
  • 8. The system of claim 6, wherein the at least one spring is an axial spring and is operatively connected to the actuator shaft.
  • 9. The system of claim 6, wherein the at least one spring is a torsion spring operatively connected to at least one pivot point of each of the first and second distal assemblies.
  • 10. The system of claim 1, wherein each of the first and second distal assemblies comprises a flexural member configured to spring bias each of the first and second distal assemblies towards the closed position, wherein the flexural member is made of nitinol and comprises a beam structure selected from the group consisting of a slotted beam, a solid beam, and a hinged beam.
  • 11. The system of claim 10, wherein each of the flexural members comprises a living hinge at a pivot point of the first and second distal assemblies, respectively.
  • 12. The system of claim 1, wherein each of the first and second proximal elements is attached to the center portion.
  • 13. The system of claim 1, wherein the first proximal element is attached to the first distal strut and the second proximal element is attached to the second distal strut.
  • 14. The system of claim 1, wherein the actuator rod is rotatable and comprises a threaded fastener at the distal end thereof, the threaded fastener configured to connect the actuator shaft of the implantable fixation device by a threaded connection.
  • 15. The system of claim 1, wherein distal movement of the actuator rod moves each of the first and second distal assemblies towards the extended position, and proximal movement of the actuator rod moves each of the first and second distal assemblies towards the closed position.
  • 16. The system of claim 1, wherein the delivery device further comprises a suture extending therefrom, the suture being connected to the release harness such that applying a proximal force to the release harness via the suture adjusts the binding plate to the perpendicular orientation.
  • 17. The system of claim 1, wherein the implantable fixation device further includes a base coupled to the first and second distal assemblies,the actuator shaft is coupled to the base such that proximal-distal movement of the actuator shaft correspondingly moves the base in a proximal-distal direction, andthe center portion is positioned between the base and the locking mechanism.
  • 18. The system of claim 1, wherein the actuator shaft extends proximally from the center portion.
  • 19. The system of claim 18, wherein the actuator shaft extends proximally from the center portion after the actuator rod is released therefrom.
  • 20. The system of claim 18, wherein the center portion has a tapered profile such that a proximal end thereof has a larger cross-sectional dimension than a distal end of the center portion.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit, under 35 U.S.C. § 119(e), of U.S. Provisional Patent Application No. 63/092,110, filed Oct. 15, 2020, which is incorporated herein by reference.

US Referenced Citations (198)
Number Name Date Kind
3378010 Codling et al. Apr 1968 A
3874388 King et al. Apr 1975 A
4007743 Blake Feb 1977 A
4055861 Carpentier et al. Nov 1977 A
4327736 Inoue May 1982 A
4340091 Skelton et al. Jul 1982 A
4657024 Coneys Apr 1987 A
4693248 Failla Sep 1987 A
4716886 Schulman et al. Jan 1988 A
4795458 Regan Jan 1989 A
4809695 Gwathmey et al. Mar 1989 A
4930674 Barak Jun 1990 A
5002562 Oberlander Mar 1991 A
5069679 Taheri Dec 1991 A
5098440 Hillstead Mar 1992 A
5125895 Buchbinder et al. Jun 1992 A
5147370 McNamara et al. Sep 1992 A
5171259 Inoue Dec 1992 A
5222963 Brinkerhoff et al. Jun 1993 A
5271544 Fox et al. Dec 1993 A
5327905 Avitall Jul 1994 A
5330501 Tovey et al. Jul 1994 A
5334217 Das Aug 1994 A
5363861 Edwards et al. Nov 1994 A
5389077 Melinyshyn et al. Feb 1995 A
5403326 Harrison et al. Apr 1995 A
5425744 Fagan et al. Jun 1995 A
5450860 O'Connor Sep 1995 A
5452837 Williamson, IV et al. Sep 1995 A
5456400 Shichman et al. Oct 1995 A
5456674 Bos et al. Oct 1995 A
5478353 Yoon Dec 1995 A
5542949 Yoon Aug 1996 A
5562678 Booker Oct 1996 A
5601224 Bishop et al. Feb 1997 A
5601574 Stefanchik et al. Feb 1997 A
5607462 Imran Mar 1997 A
5607471 Seguin et al. Mar 1997 A
5609598 Laufer et al. Mar 1997 A
5611794 Sauer et al. Mar 1997 A
5636634 Kordis et al. Jun 1997 A
5695504 Gifford, III et al. Dec 1997 A
5713911 Racenet et al. Feb 1998 A
5716417 Girard et al. Feb 1998 A
5741297 Simon Apr 1998 A
5755778 Kleshinski May 1998 A
5782239 Webster, Jr. Jul 1998 A
5797960 Stevens et al. Aug 1998 A
5810847 Laufer et al. Sep 1998 A
5814097 Sterman et al. Sep 1998 A
5843178 Vanney et al. Dec 1998 A
5849019 Yoon Dec 1998 A
5855601 Bessler et al. Jan 1999 A
5976159 Bolduc et al. Nov 1999 A
6015417 Reynolds, Jr. Jan 2000 A
6048351 Gordon et al. Apr 2000 A
6079414 Roth Jun 2000 A
6117144 Nobles et al. Sep 2000 A
6120496 Whayne et al. Sep 2000 A
6149658 Gardiner et al. Nov 2000 A
6165183 Kuehn et al. Dec 2000 A
6182664 Cosgrove Feb 2001 B1
6193734 Bolduc et al. Feb 2001 B1
6200315 Gaiser et al. Mar 2001 B1
6217528 Koblish et al. Apr 2001 B1
6269819 Oz et al. Aug 2001 B1
6290674 Roue et al. Sep 2001 B1
6312447 Grimes Nov 2001 B1
6332880 Yang et al. Dec 2001 B1
6346074 Roth Feb 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6461366 Seguin Oct 2002 B1
6482224 Michler et al. Nov 2002 B1
6496420 Manning Dec 2002 B2
6544215 Bencini et al. Apr 2003 B1
6551303 Van Tassel et al. Apr 2003 B1
6575971 Hauck et al. Jun 2003 B2
6599311 Biggs et al. Jul 2003 B1
6626930 Allen et al. Sep 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6669687 Saadat Dec 2003 B1
6695866 Kuehn et al. Feb 2004 B1
6719767 Kimblad Apr 2004 B1
6752813 Goldfarb et al. Jun 2004 B2
6770083 Seguin Aug 2004 B2
6797002 Spence et al. Sep 2004 B2
6837867 Kortelling Jan 2005 B2
6855137 Bon Feb 2005 B2
6875224 Grimes Apr 2005 B2
6908481 Cribier Jun 2005 B2
6926730 Nguyen et al. Aug 2005 B1
7011669 Kimblad Mar 2006 B2
7101395 Tremulis et al. Sep 2006 B2
7112207 Allen et al. Sep 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7226467 Lucatero et al. Jun 2007 B2
7556632 Zadno Jul 2009 B2
7563267 Goldfarb et al. Jul 2009 B2
7569062 Kuehn et al. Aug 2009 B1
7604646 Goldfarb et al. Oct 2009 B2
7635329 Goldfarb et al. Dec 2009 B2
7655015 Goldfarb et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7736388 Goldfarb et al. Jun 2010 B2
7811296 Goldfarb et al. Oct 2010 B2
7972323 Bencini et al. Jul 2011 B1
7981139 Martin et al. Jul 2011 B2
8057493 Goldfarb et al. Nov 2011 B2
8062313 Kimblad Nov 2011 B2
8118822 Schaller et al. Feb 2012 B2
8216230 Hauck et al. Jul 2012 B2
8216256 Raschdorf, Jr. et al. Jul 2012 B2
8303608 Goldfarb et al. Nov 2012 B2
8500761 Goldfarb et al. Aug 2013 B2
8734505 Goldfarb et al. May 2014 B2
8740920 Goldfarb et al. Jun 2014 B2
9510829 Goldfarb et al. Dec 2016 B2
10076415 Metchik et al. Sep 2018 B1
10105222 Metchik et al. Oct 2018 B1
10123873 Metchik et al. Nov 2018 B1
10130475 Metchik et al. Nov 2018 B1
10136993 Metchik et al. Nov 2018 B1
10159570 Metchik et al. Dec 2018 B1
10231837 Metchik et al. Mar 2019 B1
10238493 Metchik et al. Mar 2019 B1
10245144 Metchik et al. Apr 2019 B1
D847983 Ho et al. May 2019 S
10314586 Greenberg et al. Jun 2019 B2
10413408 Krone et al. Sep 2019 B2
10507109 Metchik et al. Dec 2019 B2
10517726 Chau et al. Dec 2019 B2
10524792 Hernandez et al. Jan 2020 B2
10595997 Metchik Mar 2020 B2
10646342 Marr et al. May 2020 B1
10779837 Lee et al. Sep 2020 B2
D902403 Marsot et al. Nov 2020 S
10856988 McNiven et al. Dec 2020 B2
20020013571 Goldfarb et al. Jan 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20030069593 Tremulis et al. Apr 2003 A1
20030167071 Martin et al. Sep 2003 A1
20040034365 Lentz et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20050267493 Schreck et al. Dec 2005 A1
20060020275 Goldfarb Jan 2006 A1
20070038293 St. Goar et al. Feb 2007 A1
20130066341 Ketai Mar 2013 A1
20170042546 Goldfarb et al. Feb 2017 A1
20170049455 Seguin Feb 2017 A1
20170239048 Goldfarb et al. Aug 2017 A1
20170265994 Krone Sep 2017 A1
20180021133 Barbarino Jan 2018 A1
20180036119 Wei et al. Feb 2018 A1
20180092661 Prabhu Apr 2018 A1
20180146964 Garcia et al. May 2018 A1
20180235657 Abunassar Aug 2018 A1
20180242976 Kizuka Aug 2018 A1
20180243086 Barbarino et al. Aug 2018 A1
20180325661 Delgado Nov 2018 A1
20180325671 Abunassar et al. Nov 2018 A1
20180344460 Wei Dec 2018 A1
20180353181 Wei Dec 2018 A1
20180360457 Ellis et al. Dec 2018 A1
20190000613 Delgado Jan 2019 A1
20190053803 Ketai et al. Feb 2019 A1
20190125536 Prabhu et al. May 2019 A1
20190151041 Ho et al. May 2019 A1
20190151089 Wei May 2019 A1
20190159899 Marsot et al. May 2019 A1
20190167197 Abunassar et al. Jun 2019 A1
20190183571 De Marchena Jun 2019 A1
20190209293 Metchik et al. Jul 2019 A1
20190247187 Kizuka Aug 2019 A1
20190274831 Prabhu Sep 2019 A1
20190321166 Freschauf Oct 2019 A1
20190321597 Van Hoven et al. Oct 2019 A1
20190343630 Kizuka Nov 2019 A1
20190350702 Hernandez Nov 2019 A1
20190350710 Ketai et al. Nov 2019 A1
20190365536 Prabhu Dec 2019 A1
20200000473 Dell Jan 2020 A1
20200060687 Hernández Feb 2020 A1
20200078173 McNiven et al. Mar 2020 A1
20200113678 McCann et al. Apr 2020 A1
20200121460 Dale et al. Apr 2020 A1
20200121894 Prabhu et al. Apr 2020 A1
20200138567 Marr et al. May 2020 A1
20200187942 Wei Jun 2020 A1
20200205829 Wei Jul 2020 A1
20200245998 Basude et al. Aug 2020 A1
20200261107 Cohen Aug 2020 A1
20200281591 Krone et al. Sep 2020 A1
20200315786 Metchik et al. Oct 2020 A1
20200323528 Khairkhahan Oct 2020 A1
20200323549 Goldfarb et al. Oct 2020 A1
20200323634 Von Oepen et al. Oct 2020 A1
20200360018 Dell et al. Nov 2020 A1
20200367871 Van Hoven et al. Nov 2020 A1
Foreign Referenced Citations (23)
Number Date Country
2 296 317 Jan 2009 CA
0 558 031 Sep 1993 EP
1 383 448 Jun 2008 EP
2 768 324 Mar 1999 FR
2 768 325 Nov 1999 FR
WO 9101689 Feb 1991 WO
WO 9212690 Aug 1992 WO
WO 94018893 Sep 1994 WO
WO 9632882 Oct 1996 WO
WO 9727807 Aug 1997 WO
WO 9807375 Feb 1998 WO
WO 9907354 Feb 1999 WO
WO 9913777 Mar 1999 WO
WO 9915223 Apr 1999 WO
WO 0003759 Jan 2000 WO
WO 0060995 Oct 2000 WO
WO 0128432 Apr 2001 WO
WO 03020179 Mar 2003 WO
WO 03049619 Jun 2003 WO
WO 2015057289 Apr 2015 WO
WO 2016178722 Nov 2016 WO
WO 2018093663 May 2018 WO
WO 2020176410 Sep 2020 WO
Non-Patent Literature Citations (1)
Entry
International Search report and Written Opinion mailed Jan. 5, 2022 in International Application No. PCT/US2021/051923.
Related Publications (1)
Number Date Country
20220117737 A1 Apr 2022 US
Provisional Applications (1)
Number Date Country
63092110 Oct 2020 US